Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
Department of Nursing, Kabale University School of Medicine, Kabale, Uganda.
BMC Public Health. 2022 Jun 29;22(1):1268. doi: 10.1186/s12889-022-13674-z.
Uganda adapted Viral load (VL) testing for monitoring HIV treatment success and virologic failure. However, there is a paucity of data on how the VL testing guidelines are followed in practice in the HIV clinics. This study determined the adherence to national guidelines on VL testing, barriers, and associated factors in persons living with HIV (PLHIV) on ART in southwestern Uganda. METHODS: We conducted a cross-sectional mixed methods study from April to May 2021 at four HIV clinics in southwestern Uganda. Patient chart review using a checklist that captured age, gender, and level of a healthcare facility, dates of ART initiation, dates VL specimens were drawn, line of ART, patient adherence to ART was done. Continuous data were summarized using mean and median and Chi-square was used for categorical data. We performed regression analysis to determine factors associated with adherence to viral load testing guidelines at a 95% level of significance. Key informant interviews with managers of the health facility, ART clinic and laboratory were carried out, and thematic analysis was conducted to explore barriers to adherence to VL testing guidelines.
The participants' mean (SD) age was 39.9(± 13.1) years, 39.5% were male, 45.8% received care at a general hospital and median duration on ART was 5 years (IQR;3-7). Of the 395 patient charts reviewed, 317 had their VL testing (80.3%) per the guidelines (defined as up to one month post due date). Receiving care at a hospital (aOR = 2.20; 95%CI 1.30-3.70; p = 0.002) and increasing patient age (aOR = 1.02; 95%CI 1.02-1.06; p = 0.020) were the factors associated with adhering to VL testing guidelines. Long turnaround time of VL results and insufficient VL testing kits were cites by providers as barriers.
We found suboptimal adherence to VL testing guidelines in PLHIV on ART in southwestern Uganda. Increasing patient age and getting care at a higher-level health facility were associated with guideline-based viral VL testing. Long turnaround time of VL test results and inadequate test kits hindered compliance to VL monitoring guidelines. Strategies that target young PLHIV and lower-level health facilities, increase the stock of consumables and shorten VL results turnaround time are needed to improve adherence to VL testing guidelines.
乌干达采用病毒载量 (VL) 检测来监测 HIV 治疗的效果和病毒学失败情况。然而,关于 VL 检测指南在 HIV 诊所的实际执行情况的数据很少。本研究旨在确定在乌干达西南部接受抗逆转录病毒治疗 (ART) 的 HIV 感染者 (PLHIV) 中,遵循国家 VL 检测指南的情况、障碍和相关因素。
我们于 2021 年 4 月至 5 月在乌干达西南部的四家 HIV 诊所进行了一项横断面混合方法研究。使用检查表对患者病历进行回顾,检查表中包含年龄、性别和医疗机构级别、ART 开始日期、VL 标本采集日期、ART 方案、患者对 ART 的依从性等信息。连续数据采用均值和中位数进行总结,分类数据采用卡方检验。我们进行了回归分析,以确定与遵守病毒载量检测指南相关的因素,置信水平为 95%。对医疗机构、ART 诊所和实验室的管理人员进行了关键知情人访谈,并进行了主题分析,以探讨遵守 VL 检测指南的障碍。
参与者的平均 (SD) 年龄为 39.9(±13.1)岁,39.5%为男性,45.8%在综合医院接受治疗,中位 ART 治疗时间为 5 年 (IQR;3-7)。在 395 份病历审查中,根据指南规定,317 份患者的 VL 检测结果 (80.3%)是在规定时间内 (定义为在截止日期后一个月内)。在医院接受治疗 (优势比 [OR] = 2.20;95%CI 1.30-3.70;p=0.002) 和患者年龄增加 (OR = 1.02;95%CI 1.02-1.06;p=0.020) 是与遵守 VL 检测指南相关的因素。提供者提到 VL 结果的周转时间长和 VL 检测试剂盒不足是遵守指南的障碍。
我们发现乌干达西南部接受 ART 的 PLHIV 对 VL 检测指南的依从性不理想。患者年龄增加和在更高级别医疗机构接受治疗与基于指南的病毒 VL 检测相关。VL 检测结果的周转时间长和检测试剂盒不足是影响 VL 监测指南依从性的障碍。需要针对年轻的 PLHIV 和较低级别的医疗机构采取策略,增加消耗品的库存并缩短 VL 结果的周转时间,以提高对 VL 检测指南的依从性。